Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

2-Isocyanoanilines and their mono-Boc-protected derivatives

Adrian Saura-Sanmartin, Carmen Lopez-Leonardo and Mateo Alajarin*
Departamento de Química Orgánica, Facultad de Química, Regional Campus of International Excellence “Campus Mare Nostrum”, Universidad de Murcia, E-30100 Murcia, Spain. E-mail: alajarin@um.es

Received 25th April 2025 , Accepted 14th July 2025

First published on 15th July 2025


Abstract

Among the variety of synthetically useful isocyanides, 2-isocyanoanilines have been scarcely reported in the chemical literature, despite the rich chemistry that expectedly could derive from the reactivities of their two functional groups. This is the case not only for the parent compound but also for most of their N-monosubstituted derivatives. The reason behind such behavior relies upon their chemical instability, apparently attributable to the presence of the N–H bond. Among these latter species, two tert-butyl carbamates are notorious exceptions, as they have been widely utilized in multicomponent reactions but poorly described. This review covers the chemistry of these compounds from a critical perspective, analyzing the causes of the instability of these privileged molecular scaffolds, as well as highlighting the reactivity of their mono-Boc-protected derivatives.


1. Introduction

Isocyanides, also named isonitriles, are highly versatile building blocks in organic synthesis. This versatility stems from the carbene-like reactivity of their divalent carbon atom, enabling them to participate in a wide array of reactions that form both carbon–carbon and carbon–heteroatom bonds. Consequently, isocyanides have been extensively utilized to synthesize a diverse range of molecules.1

They are exceptionally adaptable compounds, capable of acting as both electrophiles and nucleophiles in different chemical processes. The best-known chemical behavior of isocyanides is their participation in multicomponent reactions.2 They are potential carbon monoxide equivalents in certain transformations,3 and their carbene-like character allows them to participate in insertion reactions.4 Remarkably, isocyanides are involved in cycloaddition reactions.5 This versatility of isocyanides has made them ideal scaffolds in multicomponent reactions, thus occupying a privileged position for obtaining different adducts, highlighting their applications in the preparation of different target heterocycles.2e,6 In this scenario, the chemistry of isocyanides has aroused the interest of numerous synthetic chemists, leading to major advances in the research field, including the development of isocyanide-based multicomponent reactions in water7 and the employment of these privileged molecules in bioorthogonal chemistry.8

Beyond their rich chemistry, the handling of isocyanides turns out to be particularly complicated, mainly because of their instability.9 Indeed, these compounds can undergo self-condensation reactions, yielding oligomers and polymers, even at room temperature when stored as solids, liquids or in concentrated solutions.10

Thus, research focused on the use of these compounds aims to obtain isocyanides with enhanced reactivity while at the same time dealing with their stability. This direction has led to the incorporation of a second functional group into the carbon framework in the vicinity of the isocyano function, which results in a richer chemistry. Within this rational functionalization design, isocyano-amine-based compounds have emerged as privileged building blocks in different transformations. In the context of our recent interest in isocyanide chemistry,11 2-isocyanoanilines, 1, have attracted our attention. In this review, we highlight the chemistry of 2-isocyanoanilines, which are an enigmatic class of isocyano-amines, and their corresponding carbamates.

2. 2-Isocyanoanilines

As previously stated, isocyano-amines exhibit enhanced reactivity due to the amino functional group near the isocyano motif. Among the members of this family of compounds, the 2-isocyanoanilines are the focus of this review, more specifically, the parent compound and its mono- and disubstituted derivatives at the amino group (irrespective of the presence or absence of additional substituents on the aromatic ring). Such species captured our curiosity because they are scarcely reported, most probably due to the ortho-disubstitution. Such an assumption is based on the following observation: while unsubstituted 3- and 4-isocyanoanilines appeared (at least) in 3 and 30 publications, respectively, in a recent search in SciFinder®, 2-isocyanoaniline 1 has only been reported in one recent publication12 as one of the products resulting from the photoirradiation of monomeric benzimidazole isolated in a cryogenic argon matrix at 15 K. Its formation is explained as resulting from the ring opening of the imidazole moiety (2), coupled with an H-shift from C2 to N1 (Scheme 1). This isocyano-amine was not isolated but only spectroscopically detected.
image file: d5ob00677e-s1.tif
Scheme 1 Synthesis of 2-isocyanoaniline (1).

Apparently, 2-isocyanoaniline 1 is a particularly unstable compound. Thus, while the reaction with chloroform and a strong base (dichlorocarbene synthesis, also known as the Hofmann carbylamine reaction) of m- and p-phenylenediamines led to the respective isocyano-anilines, the same reaction with an o-phenylenediamine (3) was unsuccessful in yielding 2-isocyanoaniline 1.13 The presumed instability of 2-isocyanoaniline 1 could also be the reason why 1,2-diisocyanobenzene, a known species, has never been prepared by the above synthetic methodology starting from an o-phenylenediamine (3), probably because of the rapid consumption of 2-isocyanoaniline 1 formed as the primary product of that process.14 A recently disclosed new general method for synthesizing isocyanides from the respective primary amines, through a reaction with the in situ generated difluorocarbene, sheds light on what types of products derive from the putative 2-isocyanoanilines.15 In the case of using an o-phenylenediamine (3) as the substrate, such a reaction led to 1-difluoromethylbenzimidazole (4) (Scheme 2). As the authors of that research point out, this latter species probably arises from the cascade isocyanide formation/insertion of the isocyano group into the N–H bond in the initially formed 2-isocyanoaniline (1), thus yielding benzimidazole (2), which reacted further with a second equivalent of difluorocarbene, inserting into its N–H bond.


image file: d5ob00677e-s2.tif
Scheme 2 Formation of 1-difluoromethylbenzimidazole (4).

Under the same reaction conditions, 2-aminophenol (5) yielded benzoxazole (6), whereas an ethylenediamine derivative, 7, with a more flexible backbone, efficiently produced the corresponding dihydroimidazole 8 (Scheme 3).


image file: d5ob00677e-s3.tif
Scheme 3 Synthesis of dihydroimidazole 8.

In light of these results, it is clear that the reason for the instability of 2-isocyanoanilines (and probably other isocyano-amines) is the rapid intramolecular insertion of the isocyano group into the nearby N–H bond, which precludes their isolation and converts them into benzimidazoles (or other cyclic formamidines). In fact, this was clearly stated by F. E. Hahn, who wrote “… 2-aminophenyl isocyanide is not stable as a free molecule and cyclizes to give benzimidazole” in an article published in 2003,16 although such an assertion was not supported by a pertinent bibliographic reference. Also, the results in Schemes 2 and 3 indicate that this might be a general behaviour of isocyanides bearing nearby X–H groups, X being an electronegative element or a group such as O, S, and NH (Scheme 4).


image file: d5ob00677e-s4.tif
Scheme 4 Reactivity of isocyanides bearing X–H groups in the ortho-position.

To our knowledge, in the ortho-substituted benzene framework, such a conversion has been proved in the case of X = O, that is, in 2-isocyanophenol, this process easily occurs to give benzoxazole, either upon standing at room temperature17 or under photoirradiation.18 However, in the only report dealing with the thia-analogue X = S, 2-isocyanothiophenol, the in situ generation of this isocyanide by photolysis of benzothiazole was followed by the formation of tautomers and decyanation species, not returning back to the starting heterocycle.19 Computational studies of closely related processes, such as the formation of the non-fused analogues oxazole20 and thiazole21 from the respective open-chain OH and SH isocyano species, have also been carried out.

In addition, experimental studies on the equilibria between 2-metalated benzothiazole 9 and benzimidazoles 10 with their respective open-chain isocyanide tautomers have also been reported (Scheme 5). In the case of 2-metalated benzoxazole 11, the equilibrium is completely shifted to the acyclic isomer.22


image file: d5ob00677e-s5.tif
Scheme 5 The equilibrium between 2-metalated-benzoxazole(-benzothiazole, -benzimidazole) and their open-chain isomers.

In the present context, the chemistry of metal complexes of 2-isocyanoanilines 12 is worth a mention here. These species are formed starting from metal phenylisocyanide complexes 13 bearing, in the ortho-position to the isocyano group, a nitrogenated function that could be transformed into a primary amino group, such as nitro or azido. In several cases,16,23 the resulting isocyano-anilino complexes were transient undetected species that quickly converted into the final isolated reaction products, the respective diamino carbene complexes 14 (Scheme 6).


image file: d5ob00677e-s6.tif
Scheme 6 Formation of carbene complexes 14.

However, this is not a general behaviour, as in other cases, depending on the metal M and the additional ligands Ln, the intermediate amino-isocyano complexes 12 could be isolated and characterized, as shown in Fig. 1.23c,d,24


image file: d5ob00677e-f1.tif
Fig. 1 Amino-isocyano complexes 12.

Back to uncomplexed 2-isocyanoanilines, despite the considerations above, we found a few stable and characterized members of this class of compounds appearing in the chemical literature. Thus, we found some derivatives of the parent 2-isocyanoaniline monosubstituted at the amino group, retaining one N–H bond.25 It seems reasonable to postulate that these compounds would also undergo the intramolecular insertion of the isocyanide function into the N–H bond for finally yielding 1-substituted benzimidazoles, in a similar way to what occurs in the parent compound. However, we presumed that the nature of the substituent on the amino N atom could modulate the rate of such an insertion reaction, and so the reported examples of this class of 2-isocyanoanilines, not rapidly converting into the respective benzimidazoles, could give us hints for understanding the reasons behind their stability.

There is only one reported N-alkyl derivative of a 2-isocyanoaniline, the methyl derivative of the parent compound, although not as such species but in the form of its lithium salt 15.22b It was prepared by lithiation of 1-methylbenzimidazole (16) with MeLi at 0 °C in d8-THF and shown to be in equilibrium with the corresponding 2-lithio benzimidazole 17 (Scheme 7). This equilibrium is clearly apparent in the 13C NMR spectrum of the mixture of open and cyclic isomers.


image file: d5ob00677e-s7.tif
Scheme 7 Formation of 2-lithio benzimidazole 17.

We located only one article showing a monosubstituted N-aryl derivative of a 2-isocyanoaniline, represented in Scheme 8 as 18, R = H, Ar2 = 4-tolyl. The authors report on a visible-light-induced photoredox-catalyzed radical tandem cyclization of o-isocyano diarylamines 18 with arylthiodifluoroalkyl 2-pyridyl sulfones 19 (Scheme 8).26 These reactions work with a broad range of substrates and provide a simple and efficient method for the synthesis of 11-difluoromethyl-substituted dibenzodiazepines 20 via the addition of the fluoroalkyl radical to the isocyano carbon atom and further cyclization of the resulting imidoyl radical.


image file: d5ob00677e-s8.tif
Scheme 8 Formation of dibenzodiazepines 19.

In the experimental part of that paper, the starting o-isocyano diarylamines are not adequately described as their full characterization and spectroscopic data are not reported. For this reason, we could not check the data supporting the structure of the compound claimed to be o-CN–C6H4–NH–C6H4–CH3-p, the only diarylamine (with an NH fragment) among the starting materials in that work, mostly N-methyl partners. Furthermore, in some instances, the authors report a structure of N-substituted 2-isocyanoaniline despite the spectroscopic data not appearing to corroborate this.27,28

Some other 2-isocyanoaniline derivatives of our interest found in the chemical literature bear one electron-withdrawing substituent linked to the amino nitrogen atom. First, we will comment on (2-isocyano)phenyl cyanamide (21) (Scheme 9). This species was spectroscopically characterized by C. Wentrup et al. in an Ar matrix at low temperature, but was not isolated. Compound 21 was formed by rearrangement of the precursor carbodiimide 22, on warming from 40 K to 90 K in the Ar matrix.


image file: d5ob00677e-s9.tif
Scheme 9 Formation of (2-isocyano)phenyl cyanamide 21.

Carbodiimide 22 resulted from the photolysis of quinoxalino-nitrene 23, which itself was formed by a flash-vacuum thermolytic treatment of tetrazolo[1,5-a]quinoxaline.29

Very recently, a couple of 2-isocyano anilides have been reported. The first one is a natural product containing an isocyano group, the lumazine peptide 24 (Scheme 10) isolated from a Hawaiian fungal strain.30 We located the second one in the supporting information of a recent paper dealing with an isocyanide heterodimerization-triggered three-component reaction, a publication by Dong, Xu and coworkers,31 in which the quinoxaline-2-carboxamide 25 derived from a 2-isocyanoaniline.


image file: d5ob00677e-s10.tif
Scheme 10 Isocyanides 24 and 25 and formation of heterocycle 26.

Unfortunately, the article did not disclose how this species was prepared, although we reasonably imagine that it could derive from the hydrolysis of an intermediate formed from an o-diisocyanobenzene homodimer. The important thing, however, is that it is stable enough for its isolation and manipulation, as the authors stated that it converted into the benzimidazole 26 under heating in DME solution at 130 °C for 1 h, a cyclization process that follows the general trend of other 2-isocyanoanilines as shown above, although it required stronger thermal conditions.

3. (2-Isocyanophenyl)carbamates

In old work by J. M. Cox et al.32 the 2-isocyanophenyl ureidocarboxylate 27 was reported as resulting from the irradiation of methyl quinoxalin-2-ylcarbamate 1-oxide (28) under acidic conditions (Scheme 11). The isocyanide 27 was isolated, crystallized from toluene and fully characterized. However, in methanol solution at room temperature, it slowly converted into benzimidazolium bis(methoxycarbonyl)amide (29), by following the habitual cyclization pattern to the corresponding benzimidazole 30 followed by methanolysis and dissociation.
image file: d5ob00677e-s11.tif
Scheme 11 Formation of benzimidazolium 29.

Five years later, the Albini group investigated the photochemistry of related quinoxaline-1-oxides.33 When the 2-methoxy derivative 31 was irradiated, the methyl (2-isocyanophenyl)carbamate 32 was obtained and characterized as a relatively stable compound (Scheme 12). In the words of the authors of this research, “… this compound is thermally unstable and can only be crystallized (cyclohexane) in a quick operation. Otherwise, it reacts by insertion of the electron-deficient isocyano group into the amidic N–H bond to yield methyl benzimidazole-1-carboxylate 33.”


image file: d5ob00677e-s12.tif
Scheme 12 Formation of benzimidazole 33.

These latter examples apparently indicate that an EWG on the amino group contributes to stabilization of the isocyano anilines.

3.1. tert-Butyl (2-isocyanophenyl)carbamates

Last but not least, two additional examples of carbonyl-substituted 2-isocyanoanilines should be cited apart. In contrast to the thermally unstable and scarcely utilized methyl carbamate derivative 32 shown above, a couple of tert-butyl analogues, tert-butyl (2-isocyanophenyl)carbamates 34a,b (Scheme 13), are apparently stable enough to be synthetically useful functionalized isocyanides. As a proof of that, both have been used in a number of multicomponent processes, characteristic of isocyanides, namely, the Ugi and Passerini reactions, as shown below.
image file: d5ob00677e-s13.tif
Scheme 13 Formation of isocyanides 34.

Remarkably, we were unable to find detailed experimental procedures describing the syntheses of compounds 34a,b. The oldest reference where 34a appears34 did not show information concerning its preparation, whereas in the following paper on the time scale,35 it was mentioned that these compounds were commercially available. In one of these articles,36 a little piece of unprecise information on the preparation of 34a was given, indicating that N-Boc-1,2-phenylenediamine was the starting material. Some additional details on 34a appeared in one of the later publications on this isocyanide,37 where it was stated that the reagent is formed in situ under acidic conditions. For completing this information, we consider appropriate to point out that the two most reasonable chemical precursors of 34a are the above-mentioned N-Boc-o-phenylenediamine and N-Boc-N′-formyl-o-phenylenediamine.

In the usual multicomponent reactions underwent by isocyanides, tert-butyl (2-isocyanophenyl)carbamates 34a,b proved to be ideal substrates to achieve more complex synthetic sequences than those obtained with simpler aryl isocyanides, taking advantage of the easy deprotection of their amino group at the end of the multicomponent process, thus enabling the occurrence of further intramolecular processes involving the free NH group. One of the early examples using tert-butyl (2-isocyanophenyl)carbamate 34a to synthesize a heterocycle followed a Passerini reaction–amine deprotection–acyl migration reaction (PADAM) sequence.35 This strategy involved a Passerini condensation between 34a, carbamate-functionalized aldehyde 35 and carboxylic acid 36, affording product 37 (Scheme 14). The subsequent double deprotection of the carbamate groups using a trifluoroacetic acid (TFA)/DCM mixture afforded diamine 38. Interestingly, during this protocol, an acyl migration is accomplished, changing the position of the acyl group, which comes from the carboxylic acid reactant in the newly generated benzimidazole. This migration was carried out by stirring this product in trifluoroethanol (TFE)/MeOH, thus leading to 39. The final microwave irradiation in a TFA/1,2-dichloroethane (DCE) mixture afforded a series of benzimidazoles 40 through an intramolecular cyclization, constituting a convenient methodology for high-throughput synthesis.


image file: d5ob00677e-s14.tif
Scheme 14 Synthesis of benzimidazoles 40 using 34a as the starting material.

The Ugi reaction, which is a multicomponent reaction involving the employment of isocyanides, has been widely employed in the preparation of target heterocycles.6g,38 In this scenario, tert-butyl (2-isocyanophenyl)carbamates 34a,b have made available a wide variety of heterocycles due to their interesting reactivity. One of the early examples employed 34a to synthesize bis-heterocycles through a tandem Ugi-deprotection–cyclization–decarboxylation methodology.39 The synthesis proceeded through the prior formation of a Schiff base between amine 41 and ethyl glyoxalate (42) using TFE as the solvent. Subsequently, isocyanide 34a and carboxylic acid 43 were added, thus leading to the corresponding Ugi adduct 44 (Scheme 15). The heating treatment of adduct 44 under microwave irradiation using TFA in DCE resulted in the obtention of a series of benzimidazole-quinoxalines 45 through a tandem double ring formation. These cyclizations proceeded through the formation of a diamine-based intermediate via deprotection of the carbamate groups. Further treatment of some derivatives 45 using the same protocol but increasing time and temperature led to the decarboxylation of the products to form bis-heterocycles 46 in high yields. Interestingly, when using this protocol directly employing the suitable Ugi adducts 44, the direct formation of the target benzimidazole-quinoxalines 46 was accomplished via a sequential deprotection–cyclodehydration–decarboxylation strategy. Remarkably, control over the bis-heterocycle that is formed is possible by changing the temperature and microwave irradiation time.


image file: d5ob00677e-s15.tif
Scheme 15 Synthesis of benzimidazoles 45 and 46 through multicomponent Ugi reactions using 34a as the starting material.

Besides the formation of benzimidazole rings, isocyanide 34a has also been employed to obtain different target heterocycles, such as benzodiazepine-based scaffolds, which turn out to be highly valuable in the pharmaceutical industry.40 This synthesis was accomplished through a four-component Ugi-azide reaction, which replaced the carboxylic acid with azidotrimethylsilane (47). In this protocol, the azide acts as a nucleophile, trapping the nitrilium intermediates, which undergo intramolecular cyclization in order to provide the corresponding tetrazole. Thus, the multicomponent reaction of 34a, 47, amine 48 and arylglyoxaldehyde 49 led to the formation of a series of adducts 50 (Scheme 16). The subsequent microwave treatment using a TFA/DCE mixture yielded benzodiazepines 51 in moderate yields through the sequential deprotection–cyclization of the Ugi adduct.


image file: d5ob00677e-s16.tif
Scheme 16 Synthesis of dibenzodiazepines 51 using 34a as the starting material.

The stereoselective synthesis of benzimidazol-2-one derivatives employing compound 34a as one of the components that yields the intermediate Ugi adduct has been reported through the formation of a benzodiazepine-based compound.41 The synthetic protocol was initiated through a Ugi reaction employing 34a, carboxylic acid 52, glyoxaldehyde 53 and amine 54, which yielded adduct 55 (Scheme 17). The subsequent microwave irradiation in TFA/DCE afforded the bis-heterocyclic 1,5-benzodiazepine-1,4-benzodiazepine 56 in moderate to good yields. The subsequent heating of this compound promoted a rearrangement that afforded the target benzimidazol-2-ones 57, showing only the Z configuration, in excellent yields. This protocol allows different heterocycles of interest to be obtained depending on the cascade of events taking place, thereby illustrating once again the versatility of isocyanide 34a in the synthesis of a wide variety of relevant molecules. Indeed, while stopping the reaction after microwave irradiation leads to bis-benzodiazepines, further thermal treatment stereoselectively yields different bis-heterocyclic compounds.


image file: d5ob00677e-s17.tif
Scheme 17 Synthesis of bis-benzodiazepines 56 and Z-benzimidazole-2-ones 57 using 34a as the starting material.

The combination of a Ugi reaction followed by a tandem deprotection reaction–intramolecular cyclization protocol, using tert-butyl (2-isocyanophenyl)carbamates 26a,b as starting materials, has facilitated the preparation of a vast pool of heterocycles, such as benzodiazepines,42 bis-benzimidazoles,43 hydantoins,44 and pyrrolopyridinones.37 However, undoubtedly, these isocyanides have found their privileged implementation in the preparation of benzimidazole-based derivatives in which this heterocyclic nucleus is fused to others, including piperazine,45 isoquinoline,46 diazepinone,47 pyrazine,48 quinoxalinone,49 quinoxaline50 and isoindolinone.51

4. N,N-Disubstituted 2-isocyanoanilines

Finally, at this point, the reader might wonder if N,N-disubstituted 2-isocyanoanilines are known and stable substances. A substructure SciFinder search for such species, counting those with two C-linked groups at the amino N atom, retrieved 56 of these compounds, discounting a few more in which the amino N atom is embedded into a heterocyclic nucleus. The vast majority of those 56 compounds were N-aryl-N-methyl derivatives (50) that have been used for radical or palladium-mediated additions at the isocyano carbon atom and further cyclizations (cycloimidoylations) on the nearby N-aryl group, yielding 5-methyl-11-substituted dibenzodiazepines 58 (Scheme 18).26,52
image file: d5ob00677e-s18.tif
Scheme 18 Synthesis of dibenzodiazepines 58.

Notwithstanding, the N,N-dimethyl, diethyl, dipropyl, diallyl or dibenzyl partners and similar species combining two of these simple alkyl groups at the amino N atom, among the examples of N,N-disubstituted 2-isocyanoanilines, have not been reported up to now.

This is the reason behind our belief that the more nucleophilic the amino group of the 2-isocyanoanilines is, the more unstable these compounds are. Such assumption is in concordance with the proved stability of the mono-Boc derivatives commented above, bearing a N atom of diminished nucleophilicity, and also with the apparent stability of a wide range of related phenylisocyanides with an ortho N atom lacking nucleophilic characteristics because it is embedded into an heteroaromatic ring (pyrrole, indole, imidazole, benzimidazole, 1,2,3- and 1,2,4-triazole, tetrazole, and others).53

5. Conclusions

From browsing the reported examples of 2-isocyanoanilines, with attention to the preparation, stability and chemistry of the scarce N-monosubstituted derivatives, some conclusions can be drawn: (i) the parent, 2-isocyanoaniline, is an unstable non-isolated compound, quickly converting into its cyclic isomer, benzimidazole, under normal conditions; (ii) N-alkyl or aryl monosubstituted derivatives (still with one N–H bond) are practically unknown; (iii) a carbonyl group linked to the amino N atom (derivatives with an NH–CO fragment) apparently confers stability to these species, when compared with the parent compound and alkyl/aryl monosubstituted analogues; (iv) by heating in solution, some of these NH–CO derivatives are converted into the respective 1-acyl benzimidazoles; and (v) the NH-Boc fragment is particularly efficient in stabilizing the 2-isocyanophenyl NH species, apparently allowing the isolation and characterization of the two reported examples as well as their synthetic applications.

To our knowledge, the instability of 2-isocyanoanilines and some of their NH-substituted derivatives has been neither generally recognized up to now, and for this reason, nor rationalized. The observed conversion of these compounds into their cyclic isomeric benzimidazoles can be understood as resulting from the isocyanide insertion into the ortho-positioned N–H bond. This type of reaction, the insertion of NC groups into N–H bonds, is a known process although it generally requires the catalysis of Lewis acids or transition metals.4a However, NH 2-isocyanoanilines seem to cyclize in the absence of such catalysts, and the insertion reaction most probably occurs due to the proximity between the two reactive functionalities. With the data presented above, the postulation of a precise general mechanism of these cyclizations is still a challenge. We are currently involved in its study by computational means, exploring diverse potential mechanistic routes, both unimolecular and bimolecular, concerted and stepwise. In close connection with this, we are also investigating the reasons behind the stability of the mono-Boc derivatives shown above. Hopefully, the results of such computational studies will be disclosed elsewhere in the near future.

In view of the privileged reactivity of these compounds, the synthesis of numerous novel heterocycles through multicomponent reactions starting from 2-isocyanoanilines is expected, particularly those showing therapeutic activity. In addition, it is envisioned that the direction of research in this area will be focused on the development of new methods of stabilization of 2-isocyanoanilines, thus increasing the scope of the target compounds which can be synthesized.

Conflicts of interest

There are no conflicts to declare.

Data availability

No primary research results, software or code have been included, and no new data were generated or analysed as part of this review.

Acknowledgements

This work was supported by the MICINN (PID2020-113686GB-I00/MCIN/AEI/10.13039/501100011033) and Fundacion Seneca-CARM (Project 21907/PI/22). A. S.-S. gratefully acknowledges “la Caixa” Foundation (ID 100010434) for a fellowship (LCF/BQ/PR24/12050020).

References

  1. (a) I. Akritopoulou-Zanze, Curr. Opin. Chem. Biol., 2008, 12, 324–331 CrossRef CAS PubMed; (b) A. V. Gulevich, A. G. Zhdanko, R. V. A. Orru and V. G. Nenajdenko, Chem. Rev., 2010, 110, 5235–5331 CrossRef CAS PubMed; (c) V. Nenajdenko, Isocyanide chemistry: applications in synthesis and material science, Wiley-VCH, Weinheim, 2012, Print ISBN: 978-3-527-33043-0; Online ISBN: 978-3-527-65253-2 CrossRef; (d) J. Luo, G.-S. Chen, S.-J. Chen, Z.-D. Li and Y.-L. Liu, Chem. – Eur. J., 2021, 27, 6598–6619 CrossRef CAS PubMed; (e) J. Kim and S. H. Hong, Bull. Korean Chem. Soc., 2023, 44, 578–595 CrossRef CAS; (f) W. Zhang, P. Tang, M. A. Abubaker, G.-H. Hu and F.-E. Chen, Green Synth. Catal., 2025 DOI:10.1016/j.gresc.2024.08.004.
  2. (a) A. Domling and I. Ugi, Angew. Chem., Int. Ed., 2000, 39, 3168–3210 CrossRef CAS; (b) A. Dömling, Curr. Opin. Chem. Biol., 2002, 6, 306–313 CrossRef PubMed; (c) V. Nair, C. Rajesh, A. U. Vinod, S. Bindu, A. R. Sreekanth, J. S. Mathen and L. Balagopal, Acc. Chem. Res., 2003, 36, 899–907 CrossRef CAS PubMed; (d) I. Ugi, B. Werner and A. Dömling, Molecules, 2003, 8, 53–56 CrossRef; (e) A. Dömling, Chem. Rev., 2006, 106, 17–89 CrossRef PubMed; (f) L. El Kaim and L. Grimaud, Tetrahedron, 2009, 65, 2153–2171 CrossRef CAS; (g) J. Lei, J.-P. Meng, D.-Y. Tang, B. Frett, Z.-Z. Chen and Z.-G. Xu, Mol. Divers., 2018, 22, 503–516 CrossRef CAS PubMed; (h) S. I. Bhat, M. Kigga and M. M. Heravi, Chem. Heterocycl. Compd., 2021, 57, 709–719 CrossRef CAS; (i) M. I. Morja, R. B. Moradiya and K. H. Chikhalia, Mol. Divers., 2023, 27, 2895–2934 CrossRef CAS PubMed; (j) L. Banfi and C. Lambruschini, Mol. Divers., 2024, 28, 1–2 CrossRef CAS PubMed.
  3. M. Tobisu and N. Chatani, Chem. Lett., 2011, 40, 330–340 CrossRef CAS.
  4. (a) G. Qiu, Q. Ding and J. Wu, Chem. Soc. Rev., 2013, 42, 5257–5269 RSC; (b) S. Chakrabarty, S. Choudhary, A. Doshi, F.-Q. Liu, R. Mohan, M. P. Ravindra, D. Shah, X. Yang and F. F. Fleming, Adv. Synth. Catal., 2014, 356, 2135–2196 CrossRef CAS PubMed; (c) J. W. Collet, T. R. Roose, E. Ruijter, B. U. W. Maes and R. V. A. Orru, Angew. Chem., Int. Ed., 2020, 59, 540–558 CrossRef CAS PubMed; (d) J. W. Collet, T. R. Roose, B. Weijers, B. U. W. Maes, E. Ruijter and R. V. A. Orru, Molecules, 2020, 25, 4906 CrossRef CAS PubMed; (e) W. Wang, T. Liu, C.-H. Ding and B. Xu, Org. Chem. Front., 2021, 8, 3525–3542 RSC; (f) Z. Tashrifi, M. M. Khanaposhtani, F. Gholami, B. Larijani and M. Mahdavi, Adv. Synth. Catal., 2023, 365, 926–947 CrossRef CAS; (g) J. Kornfeind and F. F. Fleming, Tetrahedron Chem, 2024, 9, 100056 CrossRef CAS.
  5. (a) D. Moderhack, Synthesis, 1985, 1083–1096 CrossRef CAS; (b) A. Kruithof, E. Ruijter and R. V. A. Orru, Chem. - Asian J., 2015, 10, 508–520 CrossRef CAS PubMed; (c) T. Kaur, P. Wadhwa, S. Bagchi and A. Sharma, Chem. Commun., 2016, 52, 6958–6976 RSC.
  6. (a) J. Zhu, Eur. J. Org. Chem., 2003, 1133–1134 CrossRef CAS; (b) A. V. Lygin and A. de Meijere, Angew. Chem., Int. Ed., 2010, 49, 9094–9124 CrossRef CAS PubMed; (c) S. Sadjadi and M. M. Heravi, Tetrahedron, 2011, 67, 2707–2752 CrossRef CAS; (d) A. Maleki and A. Sarvary, RSC Adv., 2015, 5, 60938–60955 RSC; (e) A. Váradi, T. C. Palmer, R. N. Dardashti and S. Majumdar, Molecules, 2016, 21, 19 CrossRef PubMed; (f) Y. Wang, C. Zhang, S. Li, L. Liu, X. Feng and G. Liu, Eur. J. Org. Chem., 2023, e202300323 CrossRef CAS; (g) P. Kalhans, A. Singh, S. Mishra and S. Pandey, Org. Biomol. Chem., 2025, 23, 3243–3269 RSC.
  7. T. Nasiriani, S. Javanbakht, M. T. Nazeri, H. Farhid, V. Khodkari and A. Shaabani, Top. Curr. Chem., 2022, 380, 50 CrossRef CAS PubMed.
  8. Y. Zhu, J.-L. Liao and L. Qian, Front. Chem., 2021, 9, 670751 CrossRef CAS PubMed.
  9. B. Cerra, C. Blondeau, R. Cannaliere, M. Giustiniano, S. T. Shandiz and A. Gioiello, React. Chem. Eng., 2023, 8, 656–660 RSC.
  10. (a) F. Millich, Chem. Rev., 1972, 72, 101–113 CrossRef CAS; (b) F. Millich, Z. Cai, Y. Ren, X. Li, J. Shi, B. Tong and Y. Dong, Acc. Chem. Res., 2020, 53, 2879–2891 CrossRef PubMed; (c) M. Li, X. Fu, J. Wang, A. Qin and B. Z. Tang, Macromol. Chem. Phys., 2023, 224, 2200352 CrossRef CAS.
  11. (a) M. Alajarin, G. Cutillas-Font, C. Lopez-Leonardo, R.-A. Orenes, M. Marin-Luna and A. Pastor, J. Org. Chem., 2023, 88, 8658–8668 CrossRef CAS PubMed; (b) A. Pastor, C. Lopez-Leonardo, G. Cutillas-Font, A. Martinez-Cuezva, M. Marin-Luna, J.-A. Garcia-Lopez, I. Saura-Llamas and M. Alajarin, Org. Lett., 2025, 27, 73–79 CrossRef CAS PubMed.
  12. J. P. L. Roque, M. T. S. Rosado, R. Fausto and I. Reva, J. Org. Chem., 2023, 88, 2884–2897 CrossRef CAS PubMed.
  13. A. G. Sykes, Y. Shi, T. R. Dillingham, T. L. Porter and G. Caple, J. Electroanal. Chem., 1995, 380, 139–145 CrossRef.
  14. 1,2-Diisocyanobenzene is usually prepared by double dehydration of the bisformamide derivative of o-phenylenediamine, see: (a) Y. Ito, A. Ohnishi, H. Ohsaki and M. Murakami, Synthesis, 1988, 714–715 CrossRef CAS; (b) D. Leifert and A. Studer, Angew. Chem., Int. Ed., 2016, 55, 11660–11663 CrossRef CAS PubMed; (c) Y. Yuan, S.-Y. Zhang, W.-H. Dong, F. Wu, X.-M. Xie and Z.-G. Zhang, Adv. Synth. Catal., 2021, 363, 4216–4221 CrossRef CAS; (d) M. Rezaei-Gohar, K. Amiri, K. Aghaie, B. Nayebzadeh, A. Ariafard, F. Shiri, F. Rominger, D. Dar'in, M. Krasavin and S. Balalaie, Org. Lett., 2023, 25, 5682–5686 CrossRef CAS PubMed.
  15. Y.-X. Si, P.-F. Zhu and S.-L. Zhang, Org. Lett., 2020, 22, 9086–9090 CrossRef CAS PubMed.
  16. F. E. Hahn, V. Langenhahn, N. Meier, T. Lügger and W. P. Fehlhammer, Chem. – Eur. J., 2003, 9, 704–712 CrossRef CAS PubMed.
  17. (a) J. P. Ferris, F. R. Antonucci and R. W. Trimmer, J. Am. Chem. Soc., 1973, 95, 919–920 CrossRef CAS; (b) J. P. Ferris and F. R. Antonucci, J. Am. Chem. Soc., 1974, 965, 2014–2019 CrossRef.
  18. I. Reva, A. J. Lopes Jesus, C. M. Nunes, J. P. L. Roque and R. Fausto, J. Org. Chem., 2021, 86, 6126–6137 CrossRef CAS PubMed.
  19. A. Mahadevan, P. Kumar, S. Singh and S. Venkataramani, J. Org. Chem., 2023, 88, 10574–10585 CrossRef CAS PubMed.
  20. B. Ballotta, S. Nandi, V. Barone and S. Rampino, ACS Earth Space Chem., 2021, 5, 1071–1082 CrossRef CAS.
  21. G. A. McGibbon, J. Hrušák, D. J. Lavorato, H. Schwarz and J. K. Terlouw, Chem. – Eur. J., 1997, 3, 232–236 CrossRef CAS PubMed.
  22. (a) C. Hilf, F. Bosold, K. Harms, J. C. W. Lohrenz, M. Marsch, M. Schimeczek and G. Boche, Chem. Ber./Recl., 1997, 130, 1201–1212 CrossRef CAS; (b) C. Hilf, F. Bosold, K. Harms, M. Marsch and G. Boche, Chem. Ber./Recl., 1997, 130, 1213–1221 CrossRef CAS.
  23. (a) F. E. Hahn, C. G. Plumed, M. Münder and T. Lügger, Chem. – Eur. J., 2004, 10, 6285–6293 CrossRef CAS PubMed; (b) A. Flores-Figueroa, O. Kaufhold, K.-O. Feldmann and F. E. Hahn, Dalton Trans., 2009, 9334–9342 RSC; (c) A. C. Dumke, T. Pape, J. Kösters, K.-O. Feldmann, C. Schulte to Brinke and F. E. Hahn, Organometallics, 2013, 32, 289–299 CrossRef CAS; (d) V. Tegethoff, T. Lübbering, C. Schulte to Brinke, B. Schirmer, J. Neugebauer and F. E. Hahn, Organometallics, 2021, 40, 606–617 CrossRef CAS.
  24. (a) P. J. Fischer, L. Avena, T. D. Bohrmann, M. C. Neary, G. K. Putka and K. P. Sullivan, Organometallics, 2014, 33, 1300–1309 CrossRef CAS; (b) T. Lübbering, P. D. Dutschke, A. Hepp and F. E. Hahn, Organometallics, 2021, 40, 3775–3784 CrossRef.
  25. N,N-Disubstituted 2-isocyanoanilines are not so scarcely reported as the monosubstituted analogues.
  26. Y.-X. Liang, Q.-W. Ai, Z.-X. Yang and Y.-L. Zhao, Eur. J. Org. Chem., 2024, e202400731 CrossRef CAS.
  27. M.-W. Chen, X.-G. Zhang, P. Zhong and M.-L. Hu, Synthesis, 2009, 1431–1436 CAS.
  28. (a) G.-L. Gao, C. Yang and W. Xia, Chem. Commun., 2017, 53, 1041–1044 RSC; (b) S. A. Miller, B. van Beek, T. A. Hamlin, F. M. Bickelhaupt and N. E. Leadbeater, J. Fluorine Chem., 2018, 214, 94–100 CrossRef CAS.
  29. D. Kvaskoff, M. Vosswinkel and C. Wentrup, J. Am. Chem. Soc., 2011, 133, 5413–5424 CrossRef CAS PubMed.
  30. C. Wang, X. Wu, H. Bai, K. A. Uz Zaman, S. Hou, J. Saito, S. Wongwiwatthananukit, K. S. Kim and S. Cao, J. Nat. Prod., 2020, 83, 2233–2240 CrossRef CAS PubMed.
  31. L. Bao, M. Li, L. Zhang, Y. Xue, J. Dong and X. Xu, Org. Lett., 2023, 25, 2366–2371 CrossRef CAS PubMed.
  32. R. A. Burrell, J. M. Cox and E. G. Savins, J. Chem. Soc., Perkin Trans. 1, 1973, 2707–2713 RSC.
  33. A. Albini, R. Colombi and G. Minoli, J. Chem. Soc., Perkin Trans. 1, 1978, 924–928 RSC.
  34. G. S. Nichol, Z. Xu, C. E. Kaiserb and C. Hulme, Acta Crystallogr., Sect. E:Struct. Rep. Online, 2011, 67, o23–o24 CrossRef CAS PubMed.
  35. A. Y. Shaw, F. Medda and C. Hulme, Tetrahedron Lett., 2012, 53, 1313–1315 CrossRef CAS PubMed.
  36. Z. Xu, M. Ayaz, A. A. Cappelli and C. Hulme, ACS Comb. Sci., 2012, 14, 460–464 CrossRef CAS PubMed.
  37. Y. Li, J. Lei, Z.-Z. Chen, D.-Y. Tang, H. Yuan, M. Wang, J. Zhu and Z.-G. Xu, Eur. J. Org. Chem., 2016, 5770–5776 CrossRef CAS.
  38. (a) M. Ghobadi, H. Narimani and M. Kazemi, J. Chem. Synth. Chem., 2023, 2, 81–105 Search PubMed; (b) C. Liu, L. G. Voskressensky and E. V. Van der Eycken, Chem. – Eur. J., 2024, 30, e202303597 CrossRef CAS PubMed; (c) E. Fotopoulou, P. K. Anatasiou, C. Tomza and C. G. Neochoritis, Tetrahedron Green Chem., 2024, 3, 100044 CrossRef.
  39. Z. Xu, A. Y. Shaw, G. S. Nichol, A. P. Cappell and C. Hulme, Mol. Divers., 2012, 16, 607–612 CrossRef CAS PubMed.
  40. S. Gunawan, M. Ayaz, F. De Moliner, B. Frett, C. Kaiser, N. Patrick, Z. Xu and C. Hulme, Tetrahedron, 2012, 68, 5606–5611 CrossRef CAS PubMed.
  41. Z. Xu, G. Martinez-Ariza, A. P. Cappelli, S. A. Roberts and C. Hulme, J. Org. Chem., 2015, 80, 9007–9015 CrossRef CAS PubMed.
  42. (a) Z. Xu, A. Y. Shaw, J. Dietrich, A. P. Cappelli, G. Nichol and C. Hulme, Mol. Divers., 2012, 16, 73–79 CrossRef CAS PubMed; (b) Z. Xu, F. De Moliner, A. P. Capelli, M. Ayaz and C. Hulme, Synlett, 2014, 225–228 CAS; (c) G.-T. Song, Z.-G. Xu, D.-Y. Tang, S.-Q. Li, Z.-G. Xie, H.-L. Zhong, Z.-W. Yang, J. Zhu, J. Zhang and Z.-Z. Chen, Mol. Divers., 2016, 20, 575–580 CrossRef CAS PubMed.
  43. M. Ayaz, G. Martinez-Ariza and C. Hulme, Synlett, 2014, 1680–1684 Search PubMed.
  44. F. Medda, G. Martinez-Ariza and C. Hulme, Tetrahedron Lett., 2015, 56, 5295–5298 CrossRef CAS.
  45. G.-T. Song, S.-Q. Li, Z.-W. Yang, J.-H. Yuan, M.-S. Wang, J. Zhu, Z.-Z. Chen and Z.-G. Xu, Tetrahedron Lett., 2015, 56, 4616–4618 CrossRef CAS.
  46. W.-L. Liao, S.-Q. Li, J. Wang, Z.-Y. Zhang, Z.-W. Yang, D. Xu, C. Xu, H.-T. Lan, Z.-Z. Chen and Z.-G. Xu, ACS Comb. Sci., 2016, 18, 65–69 CrossRef CAS PubMed.
  47. S.-Q. Li, H. Gao, J. Lei, J. Wang, J. Xu, Z.-Z. Chen and Z.-G. Xu, RSC Adv., 2016, 6, 8461–8464 RSC.
  48. Y. Li, X. Wei, S. Bai, Z.-G. Xu and M. Lv, J. Heterocycl. Chem., 2019, 56, 3429–3434 CrossRef CAS.
  49. Z.-Z. Chen, J. Zhang, D.-Y. Tang and Z.-G. Xu, Tetrahedron Lett., 2014, 55, 2742–2744 CrossRef CAS.
  50. M. Ayaz, Z. Xu and C. Hulme, Tetrahedron Lett., 2014, 55, 3406–3409 CrossRef CAS PubMed.
  51. J. Lei, Z.-G. Xu, S.-Q. Li, J. Xu, J. Zhu and Z.-Z. Chen, Mol. Divers., 2016, 20, 859–865 CrossRef CAS PubMed.
  52. (a) W. Hu, F. Teng, H. Hu, S. Luo and Q. Zhu, J. Org. Chem., 2019, 84, 6524–6535 CrossRef CAS PubMed; (b) S. Yuan, Y. Liu, M. Ni, T. Hao, Y. Peng and Q. Ding, Chem. Commun., 2022, 58, 10985–10988 RSC; (c) S. Yuan, X. Liu, Z. Huang, S. Gui, Y. Diao, Y.-Y. Peng and Q. Ding, J. Org. Chem., 2022, 87, 16542–16549 CrossRef CAS PubMed; (d) Y. Liu, W. Gao, S. Yuan, M. Ni, T. Hao, C. Zeng, X. Xu, Y. Fu, Y. Peng and Q. Ding, Org. Biomol. Chem., 2023, 21, 4257–4263 RSC; (e) X. Liu, S. Yuan, Y. Liu, M. Ni, J. Xu, S. Gui, Y.-Y. Peng and Q. Ding, J. Org. Chem., 2023, 88, 198–210 CrossRef CAS PubMed; (f) A.-Y. Li, R. Xie, Q. Zhou, P.-F. Huang and Y. Liu, Org. Biomol. Chem., 2025, 23, 1874–1882 RSC.
  53. (a) K. Kobayashi, S. Irisawa, T. Matoba, T. Matsumoto, K. Yoneda, O. Morikawa and H. Konishi, Bull. Chem. Soc. Jpn., 2001, 74, 1109–1114 CrossRef CAS; (b) Z. He, M. Bae, J. Wu and T. F. Jamison, Angew. Chem., Int. Ed., 2014, 53, 14451–14455 CrossRef CAS PubMed; (c) M. Damai, N. Guzzardi, V. Lewis, Z. X. Rao, D. Sykes and B. Patel, RSC Adv., 2023, 13, 29561–29567 RSC; (d) S. Yang, X. Tan, D. Liu, H. Jiang and W. Wu, Adv. Synth. Catal., 2025, 367, e202500031 CrossRef CAS.

Footnote

Dedicated to the memory of Prof. Rafael Pedrosa (1948–2023).

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.